You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy

Around 55,000 people in Scotland are currently living with epilepsy. Significant treatment needs remain for those suffering from the treatment-resistant disease.